ArticleAnalytical and bioanalytical chemistry2026
A novel dual responsive DNA walking machine for the cell apoptotic signaling pathway.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Precisely elucidating the apoptotic signaling pathway is crucial for monitoring apoptosis, advancing drug discovery, and improving treatments for human diseases. However, it is challenging to directly describe these pathways, due to the fact that individual signaling molecule detection cannot establish a causal relationship. In this paper, we developed a dual responsive DNA nanomachine capable of simultaneously detecting both upstream and downstream signaling molecules in an apoptotic signaling pathway. The walking machine is constructed by anchoring a few blocker-myc/blocker-Cyt c/DNAzyme triple DNA strands containing complementary domains for c-Myc mRNA (blocker-myc) and an aptamer for Cyt c (blocker-Cyt c), together with an abundance of Cy5-labeled DNA-RNA chimeric substrates onto gold nanoparticles (AuNPs) through an Au-S bond. Upon activation by the c-Myc mRNA and Cyt c, the "AND" logic gate designed by blocker-myc/blocker-Cyt c/DNAzyme triple DNA strands could be "open," resulting in the autonomous movement of the DNAzyme along the AuNP and outputting a fluorescence signal. Unlike conventional methods that detect single molecules, this dual responsive DNA walking nanomachine achieves direct profiling of a specific signaling pathway by correlating two key signaling molecules. Our strategy holds significant potential for investigating apoptotic mechanisms, elucidating signaling pathways, and facilitating drug screening.
Indexed as
Identifiers
41225213What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.